https://www.pharmaradar360.com/article/da6d995376702ffcPharmaRadar360en2026-04-18T14:08:55.000ZIt doesn’t matter how much you sit — walking more could lower your risk of death and diseasehttps://www.pharmaradar360.com/article/0a4c993a8c315e0cPharmaRadar360en2026-04-18T13:48:37.000ZUFRJ reúne professores eméritos em articulação permanente por ideias e soluções para a universidadehttps://www.pharmaradar360.com/article/6ba122f96e0e47d7PharmaRadar360en2026-04-18T13:05:40.000ZLive Updates From the AACR Annual Meeting 2026: Saturday, April 18https://www.pharmaradar360.com/article/c65a776f458dcef8PharmaRadar360en2026-04-18T10:00:24.000ZRevMed’s stunning success; FDA to reclassify peptides; and morehttps://www.pharmaradar360.com/article/689dc2fdedbc1cfaPharmaRadar360en2026-04-18T08:34:06.000ZOur Research Group at the PBP World Meeting 2026https://www.pharmaradar360.com/article/f0faa58cb542074cPharmaRadar360en2026-04-18T07:32:36.000ZArtificial neurons successfully communicate with living brain cellshttps://www.pharmaradar360.com/article/c7744c44b1319105PharmaRadar360en2026-04-18T07:30:00.000ZSevere malaria may affect children’s cognitive abilities more than a decade laterhttps://www.pharmaradar360.com/article/cc52e31ee9330290PharmaRadar360en2026-04-18T03:27:27.000ZEating more fruits and vegetables tied to unexpected lung cancer riskhttps://www.pharmaradar360.com/article/0aef460b1901a96aPharmaRadar360en2026-04-18T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/d948d382ef12f4e6PharmaRadar360en2026-04-18T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/c7928f0b322465ffPharmaRadar360en2026-04-18T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/28b243d3630c33efPharmaRadar360en2026-04-18T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/be9e23a8870b11a6PharmaRadar360en2026-04-18T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/100fb70977f3d18dPharmaRadar360en2026-04-18T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/e32654f0a8cc2a1dPharmaRadar360en2026-04-18T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/e127815f1f89cc02PharmaRadar360en2026-04-18T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/b8485bbeb48ffcefPharmaRadar360en2026-04-18T00:00:00.000Zlegal update regarding risdiplamhttps://www.pharmaradar360.com/article/989a32fec3f6c0cbPharmaRadar360en2026-04-18T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/87556421a375faa5PharmaRadar360en2026-04-18T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/3f6a35c16f5ddbf4PharmaRadar360en2026-04-18T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/e6a4e6a82a5fc9f7PharmaRadar360en2026-04-18T00:00:00.000Z6203https://www.pharmaradar360.com/article/6c719d61c43b8772PharmaRadar360en2026-04-18T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/5a13a2c4d22764d3PharmaRadar360en2026-04-17T21:04:45.000ZPew Biomedical Scholars – Limited Submissionhttps://www.pharmaradar360.com/article/6c27b0b8e0af5c65PharmaRadar360en2026-04-17T21:03:48.000ZInnovación UC reemplaza la evaluación subjetiva del vino por datos medibleshttps://www.pharmaradar360.com/article/e6b126e68bc66b7ePharmaRadar360en2026-04-17T20:53:13.000ZIn hopeful sign for biotech, obesity treatment firm Kailera raises $625 million in upsized IPOhttps://www.pharmaradar360.com/article/eca3ec74a72c0f80PharmaRadar360en2026-04-17T20:51:24.000ZKailera nets $625M in one of biotech’s biggest-ever IPOshttps://www.pharmaradar360.com/article/e138125857acf074PharmaRadar360en2026-04-17T20:30:00.000ZUNFPA Funding and Kemp-Kasten: An Explainerhttps://www.pharmaradar360.com/article/df017f2bf95d1579PharmaRadar360en2026-04-17T20:00:00.000ZNotice of REDCap data security incidenthttps://www.pharmaradar360.com/article/9b393ddab24317faPharmaRadar360en2026-04-17T19:59:39.000ZExplore Carolina’s botanical history at the garden tourhttps://www.pharmaradar360.com/article/59c0505b24b6c149PharmaRadar360en2026-04-17T19:36:15.000ZInside the insect collection at the University of Minnesotahttps://www.pharmaradar360.com/article/4dba60fb2aac761fPharmaRadar360en2026-04-17T19:35:42.000ZU of M researchers launch startup aiming to reduce AI energy consumptionhttps://www.pharmaradar360.com/article/46c01b0b9f9fb3b8PharmaRadar360en2026-04-17T19:34:48.000ZUniversity of Minnesota med school dean shares ‘innovation and vision’ on visit to St. Cloudhttps://www.pharmaradar360.com/article/525c92782b5e4919PharmaRadar360en2026-04-17T18:29:00.000ZTwo Northeast Ohio changemakers triumph in competition to end cardiovascular diseasehttps://www.pharmaradar360.com/article/61c7b37be3a7c75fPharmaRadar360en2026-04-17T18:15:00.000ZProfessor Michael Laub and MIT alumni named 2025 AAAS Fellowshttps://www.pharmaradar360.com/article/993cf944321af3b1PharmaRadar360en2026-04-17T17:58:00.000ZLocal construction executive advances awareness, advocacy and heart health education in Browardhttps://www.pharmaradar360.com/article/0470c9bfe2587856PharmaRadar360en2026-04-17T17:35:00.000ZUBC researchers aim to deliver earlier warnings on the toxic drug supplyhttps://www.pharmaradar360.com/article/aada987eba981d03PharmaRadar360en2026-04-17T17:31:00.000ZFounder and CEO raises awareness and funds to end women’s No. 1 health threathttps://www.pharmaradar360.com/article/621a8e54844efad0PharmaRadar360en2026-04-17T17:17:43.000ZNew CDC pick Schwartz is praised by public health proshttps://www.pharmaradar360.com/article/83e929de77cf4b88PharmaRadar360en2026-04-17T16:58:12.000ZWhat Are the Recent Trends in Employer-Based Health Coverage?https://www.pharmaradar360.com/article/5e610ce54e3cf7c7PharmaRadar360en2026-04-17T16:49:25.000ZSPECIAL FEATURE - Bioavailability & Solubility: Experimental Techniques Combined With Computational Decision-Making Rapidly ID the Most Viable Enhancement Pathwayhttps://www.pharmaradar360.com/article/0f337f84ff934283PharmaRadar360en2026-04-17T16:47:51.000ZWhich Pregnancy Symptoms Require Urgent Care?https://www.pharmaradar360.com/article/777fae8f4db6ecbcPharmaRadar360en2026-04-17T16:33:00.000ZNine Intermountain Health Hospitals Named to Nation’s 2026 100 Top Hospitals by Modern Healthcare and Premierhttps://www.pharmaradar360.com/article/9a35214c11b1325dPharmaRadar360en2026-04-17T16:20:00.000ZProposed DTW Cigar Lounge Puts Smoke‑Free Protections at Riskhttps://www.pharmaradar360.com/article/3be8f271c3e76be4PharmaRadar360en2026-04-17T16:06:25.000ZKailera IPO interview: CEO Renaud talks biotech market, China and obesity pipelinehttps://www.pharmaradar360.com/article/9ac3e9fdc81a9ccdPharmaRadar360en2026-04-17T15:38:49.000Z#AACR26 preview: Revolution Medicines, the RAS bonanza and China ADC standoutshttps://www.pharmaradar360.com/article/0eca8fc837639a55PharmaRadar360en2026-04-17T15:32:00.000Z$1 Million gift will further research about congenital heart defectshttps://www.pharmaradar360.com/article/e409826a1d76fd07PharmaRadar360en2026-04-17T15:10:29.000ZTrevi raises $150M; Spain and Boston set up biotech fundhttps://www.pharmaradar360.com/article/9f9a730f183dd574PharmaRadar360en2026-04-17T14:35:40.000ZEmergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibilityhttps://www.pharmaradar360.com/article/db51fb73338150e1PharmaRadar360en2026-04-17T14:30:13.000ZKailera makes history with record-breaking $625m IPOhttps://www.pharmaradar360.com/article/61608da20ac74394PharmaRadar360en2026-04-17T14:11:25.000ZRoche to launch global study of Elevidys following EU rejectionhttps://www.pharmaradar360.com/article/37786e8c4e3f1423PharmaRadar360en2026-04-17T14:00:00.000ZTwo scientists to receive 2026 Ralph L. Sacco Scholarships for Brain Healthhttps://www.pharmaradar360.com/article/eb6cc6558bbcd8afPharmaRadar360en2026-04-17T14:00:00.000ZNeural population dynamics and temporal context cells in macaque medial parietal cortex support temporal order memoryhttps://www.pharmaradar360.com/article/79b70cfa5ea161ebPharmaRadar360en2026-04-17T14:00:00.000ZSomatosensory input drives membrane potential dynamics in motor cortex during voluntary limb movementhttps://www.pharmaradar360.com/article/58162789abb3796bPharmaRadar360en2026-04-17T14:00:00.000ZNew transcription signals in SARS-CoV-2 reshape virus–host interactionshttps://www.pharmaradar360.com/article/eed6993fea38a121PharmaRadar360en2026-04-17T14:00:00.000ZCircadian clock gates diurnal glucose utilizationhttps://www.pharmaradar360.com/article/952409948c107903PharmaRadar360en2026-04-17T13:56:08.000ZBy leaps and bounds, she overcomes obstacleshttps://www.pharmaradar360.com/article/b51aa89312efebf7PharmaRadar360en2026-04-17T13:32:30.000ZBiovac gets $108M backing for vaccine factory in South Africahttps://www.pharmaradar360.com/article/000e15827f490f91PharmaRadar360en2026-04-17T13:20:06.000ZRevolution Medicines' buyout price soars after pancreatic cancer winhttps://www.pharmaradar360.com/article/1351e5c7900a1789PharmaRadar360en2026-04-17T13:02:00.000ZINAKhttps://www.pharmaradar360.com/article/725a18c00ec759ccPharmaRadar360en2026-04-17T12:59:56.000ZViz.ai Wins Gold Edison Award™ for Advancing AI-Driven Clinical Workflows to Improve Hemorrhage Carehttps://www.pharmaradar360.com/article/2bd035e347d64bfbPharmaRadar360en2026-04-17T12:34:32.000ZDoctoral student uses machine learning to transform gene therapyhttps://www.pharmaradar360.com/article/daf0446f29e306a4PharmaRadar360en2026-04-17T12:17:59.000ZFIRE sheds new light on the pension debatehttps://www.pharmaradar360.com/article/db62ddab8e003ac1PharmaRadar360en2026-04-17T11:49:00.000ZEuropean Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Seasonhttps://www.pharmaradar360.com/article/e6335aa7c9011a52PharmaRadar360en2026-04-17T11:48:34.000ZReplimune cries foul on regulatory flexibility. But many Americans want a stricter FDAhttps://www.pharmaradar360.com/article/6e32d43bd04950b4PharmaRadar360en2026-04-17T11:44:33.000ZLes volets découverts sur une façade à l'Hôtel-Dieu Saint-Jacques ont révélé leurs premiers secrets !https://www.pharmaradar360.com/article/3a4f6010791f3f81PharmaRadar360en2026-04-17T11:44:05.000ZScientists discover bacteria can “explode” to spread antibiotic resistancehttps://www.pharmaradar360.com/article/7f66cf3be2405f22PharmaRadar360en2026-04-17T11:28:56.000ZKailera raises $625M IPO in biotech recordhttps://www.pharmaradar360.com/article/cdef01ceb2c9e2e3PharmaRadar360en2026-04-17T11:15:32.000ZLilly’s tirzepatide sheds lean muscle harder than Novo’s semaglutide, study suggestshttps://www.pharmaradar360.com/article/e323d6467268573fPharmaRadar360en2026-04-17T11:00:50.000ZNovartis' Vas Narasimhan heads to Anthropic's board; Metsera alum joins Structure as COOhttps://www.pharmaradar360.com/article/926d377a6970266ePharmaRadar360en2026-04-17T11:00:01.000ZHelsinki Animal Law Conference 2026: “Reimagining Justice Across Species”https://www.pharmaradar360.com/article/d047365a7d998e18PharmaRadar360en2026-04-17T10:37:12.000ZEarth Day: Putting Science at the Heart of Planetary Balancehttps://www.pharmaradar360.com/article/92f19933cda36acaPharmaRadar360en2026-04-17T10:36:43.000ZDissertation Award for Heidelberg Historianhttps://www.pharmaradar360.com/article/c28278dbb04803d9PharmaRadar360en2026-04-17T10:20:14.000ZBrownlee Brain Health Awareness April 2026https://www.pharmaradar360.com/article/ea046412663b2fb7PharmaRadar360en2026-04-17T10:03:47.000ZLes résidents des USLD de l'Hôpital Garonne font leur cinéma !https://www.pharmaradar360.com/article/b5fcd890dd0f1c50PharmaRadar360en2026-04-17T10:02:44.000ZAcerand reports first-in-human trial results for ACE-106 therapyhttps://www.pharmaradar360.com/article/96a87828ff2fcc55PharmaRadar360en2026-04-17T09:54:34.000ZAligos and Xiamen Amoytop sign deal for HBV therapyhttps://www.pharmaradar360.com/article/d27328ff8fa956b0PharmaRadar360en2026-04-17T09:44:22.000ZThe innovators working to make in vivo cell therapy a realityhttps://www.pharmaradar360.com/article/d0a4905b50c88e7fPharmaRadar360en2026-04-17T09:26:56.000ZBiomarker-led trials to guide the future of precision psychiatryhttps://www.pharmaradar360.com/article/6c3ea620dd5177bePharmaRadar360en2026-04-17T09:15:00.000ZNew Report Highlights Fructose as a Key Driver of Metabolic Diseasehttps://www.pharmaradar360.com/article/51ec70032fe0212aPharmaRadar360en2026-04-17T09:14:50.000ZFreedom of expression and recent incidentshttps://www.pharmaradar360.com/article/c76c95ce1d24ed71PharmaRadar360en2026-04-17T09:14:16.000ZLive Updates From the AACR Annual Meeting 2026: Friday, April 17https://www.pharmaradar360.com/article/a19ff0bb7ec5a11cPharmaRadar360en2026-04-17T09:11:51.000ZAspen Australia participates in the 2026 APP Conferencehttps://www.pharmaradar360.com/article/a7fedf996033ee86PharmaRadar360en2026-04-17T09:04:37.000ZFirst patient receives JANX014 dose in Janux’s trial for mCRPChttps://www.pharmaradar360.com/article/95420ae1d37ae686PharmaRadar360en2026-04-17T09:01:01.000ZDaiichi Sankyo and Interna partner for MNM-targeted delivery solutionshttps://www.pharmaradar360.com/article/bde58466b2c90159PharmaRadar360en2026-04-17T08:49:42.000ZNew publication describes the vesicular disease outbreaks of Seneca Valley virus in England in 2022https://www.pharmaradar360.com/article/43c302818b4a3334PharmaRadar360en2026-04-17T08:33:22.000ZConnecting communities to share the joy of doing sciencehttps://www.pharmaradar360.com/article/c1c11cc576488aadPharmaRadar360en2026-04-17T08:30:36.000ZTervetuloa avoimen julkaisemisen webinaareihin toukokuussahttps://www.pharmaradar360.com/article/56186a49a27f4990PharmaRadar360en2026-04-17T08:11:45.000ZRADIA Seminar: Gender, Misogyny and Extremismhttps://www.pharmaradar360.com/article/0077b4585d6a9e20PharmaRadar360en2026-04-17T08:07:42.000ZNUM4Rare: Präsenz-Kick-Off bringt Projektpartner*innen zusammenhttps://www.pharmaradar360.com/article/0fee04d20b0f95c7PharmaRadar360en2026-04-17T08:04:00.000ZIm Portrait: PD Dr. Sarah Sonnenscheinhttps://www.pharmaradar360.com/article/ac00728d30e25a86PharmaRadar360en2026-04-17T08:00:00.000ZIDIBAPS presents the Strategic Plan 2025-2028https://www.pharmaradar360.com/article/88617c4d0ba336caPharmaRadar360en2026-04-17T07:52:53.000ZMore information leads to more accurate beliefs—except in echo chambershttps://www.pharmaradar360.com/article/f8d21881d66905cbPharmaRadar360en2026-04-17T07:41:20.000ZCardiac MR for Every Radiologist: ESR steps up training effortshttps://www.pharmaradar360.com/article/029f87ab631483b3PharmaRadar360en2026-04-17T07:30:00.000ZRate shock looming, but uncertainty dominates: Huisman warns of a ‘serious problem’https://www.pharmaradar360.com/article/15fa2b246731e819PharmaRadar360en2026-04-17T07:17:58.000ZCan sparkling water boost metabolism and help with weight loss?https://www.pharmaradar360.com/article/5372eff56879110ePharmaRadar360en2026-04-17T07:02:00.000ZAbbott lowers EPS guidance on Exact Sciences buy as shares slidehttps://www.pharmaradar360.com/article/86522f3ea8a421f0PharmaRadar360en2026-04-17T07:00:00.000ZTake on Dr. Davies in the Chancellor’s Push-Up Challengehttps://www.pharmaradar360.com/article/8e37b81c6fa7978fPharmaRadar360en2026-04-17T06:58:00.000ZDr. Bennett named dentistry’s executive associate deanhttps://www.pharmaradar360.com/article/44fa1f595f7a7cffPharmaRadar360en2026-04-17T06:56:00.000ZChild Health Research Institute releases inaugural annual reporthttps://www.pharmaradar360.com/article/e91a4afefad4a3cfPharmaRadar360en2026-04-17T06:54:00.000ZUNMC for the record, April 17, 2026https://www.pharmaradar360.com/article/811f1f564281e7aaPharmaRadar360en2026-04-17T06:47:24.000ZFünf Jahre COVID-19-Impfungen – was wissen wir heute?https://www.pharmaradar360.com/article/736b1a48271075b5PharmaRadar360en2026-04-17T06:43:25.000ZFira in våren med en japansk picknick i Botaniskahttps://www.pharmaradar360.com/article/811d80a41a6e6551PharmaRadar360en2026-04-17T06:20:00.000Z#MalattieRare. Emofilia: dalla ricerca alle nuove generazioni di specialisti, il futuro della curahttps://www.pharmaradar360.com/article/a6a1b0a875b85061PharmaRadar360en2026-04-17T06:00:00.000ZOtsuka Pharmaceutical Receives Judges' Special Award at MAFF's 10th Shokuiku Activity Awards "MoguMogu Town" App Recognized for Promoting Food and Nutrition Educationhttps://www.pharmaradar360.com/article/f478e127462d8309PharmaRadar360en2026-04-17T05:58:55.000Zゴールデンウィーク期間中の院内施設休業日についてhttps://www.pharmaradar360.com/article/e05d39db1e894765PharmaRadar360en2026-04-17T05:58:06.000ZRedevelopment announced for Dandenong Hospitalhttps://www.pharmaradar360.com/article/f538cd70a12226b8PharmaRadar360en2026-04-17T03:49:55.000ZScientists discover natural hormone that reverses obesityhttps://www.pharmaradar360.com/article/183321ac3f169b81PharmaRadar360en2026-04-17T03:28:07.000ZScientists supercharge immune cells to destroy cancer more effectively